Briefing papers

Used in Scandinavia for more than 300 years, snus is providing smokers in Sweden and Norway with an alternative to combustible cigarettes, but what is it and why is it considered a safer nicotine product? Our latest Briefing Paper aims to provide the answers.

With the number of tobacco users across the continent set to rise by 2025, we look at the current state of tobacco harm reduction in the region, assessing the progress made so far and the obstacles preventing greater adoption of safer nicotine products.

Tobacco harm reduction is not only a potentially life-saving public health intervention for the world’s 1.1 billion smokers, it's also supported by international human rights law. Here we make the case for promoting tobacco harm reduction as a health rights issue.

Tobacco harm reduction is a potentially life-saving intervention that offers smokers the choice to switch to a range of safer nicotine products. Here, we provide a detailed introduction to the principles, history and evidence for this vital public health strategy.

The popularity of nicotine vaping products continues to grow around the world as smokers choose to make the switch to safer alternatives and our latest research estimates the global number of vapers increased by 20% between 2020 and 2021.

The WHO Framework Convention on Tobacco Control isn't working. Here we use the key messages from the latest Global State of Tobacco Harm Reduction report, Fighting the Last War, to argue why tobacco harm reduction must be adopted urgently by the WHO.

The UK is a world leader in tobacco harm reduction (THR), but it can still do more. Here, we argue COP9 presents the UK with the perfect opportunity to both display its THR credentials on the global stage and to champion the benefits of safer nicotine products.

With the Ninth Meeting of the Conference of the Parties (COP) to the Framework Convention on Tobacco Control (FCTC) taking place from 8 - 13 November 2021, here's our guide to explain how the meeting works.